Literature DB >> 8404918

Haemophilus test medium versus Mueller-Hinton broth with lysed horse blood for antimicrobial susceptibility testing of four bacterial species.

A L Barry1, M A Pfaller, P C Fuchs.   

Abstract

Studies were undertaken to determine whether broth microdilution susceptibility tests could be standardized by using a single medium for testing fastidious respiratory pathogens. Mueller-Hinton broth with lysed horse blood and the broth version of Haemophilus Test Medium (HTM) were directly compared. Ten orally administered agents were found to give essentially identical results in both media but minor differences were noted. Because the test are easier to read when HTM broth is used, that medium is to be preferred for routine testing of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Moraxella catarrhalis isolates by the microdilution procedure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8404918     DOI: 10.1007/bf01970963

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  5 in total

1.  Multicenter evaluation of the use of Haemophilus test medium for broth microdilution antimicrobial susceptibility testing of Streptococcus pneumoniae and development of quality control limits.

Authors:  J H Jorgensen; G V Doern; M J Ferraro; C C Knapp; J M Swenson; J A Washington
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

2.  Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).

Authors:  R N Jones; A L Barry; P C Fuchs; C Thornsberry
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

3.  Use of Haemophilus test medium for broth microdilution antimicrobial susceptibility testing of Streptococcus pneumoniae.

Authors:  J H Jorgensen; L A Maher; A W Howell
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

4.  Broth microdilution testing of Haemophilus influenzae with haemophilus test medium versus lysed horse blood broth. Canadian Haemophilus Study Group.

Authors:  S R Scriver; D E Low; A E Simor; B Toye; A McGeer; R Jaeger
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

5.  Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae.

Authors:  J H Jorgensen; J S Redding; L A Maher; A W Howell
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

  5 in total
  8 in total

1.  Identification of beta-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae with four methods and eight media.

Authors:  A L Barry; P C Fuchs; S D Brown
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Antibacterial Nucleoside-Analog Inhibitor of Bacterial RNA Polymerase.

Authors:  Sonia I Maffioli; Yu Zhang; David Degen; Thomas Carzaniga; Giancarlo Del Gatto; Stefania Serina; Paolo Monciardini; Carlo Mazzetti; Paola Guglierame; Gianpaolo Candiani; Alina Iulia Chiriac; Giuseppe Facchetti; Petra Kaltofen; Hans-Georg Sahl; Gianni Dehò; Stefano Donadio; Richard H Ebright
Journal:  Cell       Date:  2017-06-15       Impact factor: 41.582

3.  Towards a Standardized Method for Broth Microdilution Susceptibility Testing of Haemophilus parasuis.

Authors:  Sandra Prüller; Conny Turni; Patrick J Blackall; Martin Beyerbach; Günter Klein; Lothar Kreienbrock; Katrin Strutzberg-Minder; Heike Kaspar; Diana Meemken; Corinna Kehrenberg
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

4.  Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin.

Authors:  P C Fuchs; A L Barry; S D Brown
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

5.  In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens.

Authors:  A L Barry; P C Fuchs
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

6.  In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.

Authors:  A L Barry; M A Pfaller; P C Fuchs; R R Packer
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

7.  Transcription inhibition by the depsipeptide antibiotic salinamide A.

Authors:  David Degen; Yu Feng; Yu Zhang; Katherine Y Ebright; Yon W Ebright; Matthew Gigliotti; Hanif Vahedian-Movahed; Sukhendu Mandal; Meliza Talaue; Nancy Connell; Eddy Arnold; William Fenical; Richard H Ebright
Journal:  Elife       Date:  2014-04-30       Impact factor: 8.140

8.  Salinamide F, new depsipeptide antibiotic and inhibitor of bacterial RNA polymerase from a marine-derived Streptomyces sp.

Authors:  Hossam M Hassan; David Degen; Kyoung Hwa Jang; Richard H Ebright; William Fenical
Journal:  J Antibiot (Tokyo)       Date:  2014-09-17       Impact factor: 2.649

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.